$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Human Microbiome and HIV/AIDS 원문보기

Current HIV/AIDS reports, v.9 no.1, 2012년, pp.44 - 51  

Saxena, Deepak ,  Li, Yihong ,  Yang, Liying ,  Pei, Zhiheng ,  Poles, Michael ,  Abrams, William R. ,  Malamud, Daniel

초록이 없습니다.

참고문헌 (69)

  1. Nat Med JM Brenchley 12 1365 2006 10.1038/nm1511 Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-71. 

  2. Curr Opin HIV AIDS B Kanwar 5 151 2010 10.1097/COH.0b013e328335c0c1 Kanwar B, Favre D, McCune JM. Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS. 2010;5:151-7. 

  3. N Engl J Med C Fiocchi 353 2078 2005 10.1056/NEJMcibr053171 Fiocchi C. One commensal bacterial molecule. All we need for health? N Engl J Med. 2005;353:2078-80. 

  4. Science TT MacDonald 307 1920 2005 10.1126/science.1106442 MacDonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307:1920-5. 

  5. Gastroenterology TT MacDonald 140 1768 2011 10.1053/j.gastro.2011.02.047 •• MacDonald TT, Monteleone I, Fantini MC, et al. Regulation of homeostasis and inflammation in the intestine. Gastroenterology. 2011;140:1768-75. Explains some aspects of gut immunity that could alter the delicate balance between inflammatory and tolerogenic responses and result in chronic gastrointestinal tract inflammation in patients. 

  6. Science SR Gill 312 1355 2006 10.1126/science.1124234 Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355-9. 

  7. Nature AL Kau 474 327 2011 10.1038/nature10213 Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327-36. 

  8. Environ Microbiol RE Ley 9 3 2007 10.1111/j.1462-2920.2006.01222_3.x Ley RE, Knight R, Gordon JI. The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology. Environ Microbiol. 2007;9:3-4. 

  9. Cell RE Ley 124 837 2006 10.1016/j.cell.2006.02.017 Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837-48. 

  10. J Physiol PJ Turnbaugh 587 4153 2009 10.1113/jphysiol.2009.174136 Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol. 2009;587:4153-8. 

  11. Cell PJ Turnbaugh 134 708 2008 10.1016/j.cell.2008.08.025 Turnbaugh PJ, Gordon JI. An invitation to the marriage of metagenomics and metabolomics. Cell. 2008;134:708-13. 

  12. Nature PJ Turnbaugh 449 804 2007 10.1038/nature06244 Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007;449:804-10. 

  13. Genome Res J Peterson 19 2317 2009 10.1101/gr.096651.109 Peterson J, Garges S, Giovanni M, et al. The NIH human microbiome project. Genome Res. 2009;19:2317-23. 

  14. Science J Lederberg 288 287 2011 10.1126/science.288.5464.287 Lederberg J. Infectious history. Science. 2011;288:287-93. 

  15. J Clin Microbiol M Anderson 42 753 2004 10.1128/JCM.42.2.753-758.2004 Anderson M, Bollinger D, Hagler A, et al. Viable but nonculturable bacteria are present in mouse and human urine specimens. J Clin Microbiol. 2004;42:753-8. 

  16. Nat Rev Microbiol C Dehio 3 621 2005 10.1038/nrmicro1209 Dehio C. Bartonella-host-cell interactions and vascular tumour formation. Nat Rev Microbiol. 2005;3:621-31. 

  17. 10.1016/j.ijantimicag.2007.06.024 Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents. 30, Supplement 2007, 1:7-15. 

  18. Ji X, Pushalkar S, Li Y, et al. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis. 2011. doi: 10.1111/j.1601-0825.2011.01848 . 

  19. J Clin Microbiol Y Li 45 81 2007 10.1128/JCM.01622-06 Li Y, Ge Y, Saxena D, et al. Genetic profiling of the oral microbiota associated with severe early-childhood caries. J Clin Microbiol. 2007;45:81-7. 

  20. J Dent Res Y Li 84 559 2005 10.1177/154405910508400614 Li Y, Ku CY, Xu J, et al. Survey of oral microbial diversity using PCR-based denaturing gradient gel electrophoresis. J Dent Res. 2005;84:559-64. 

  21. FEMS Immunol Med Microbiol S Pushalkar 61 269 2011 10.1111/j.1574-695X.2010.00773.x Pushalkar S, Mane SP, Ji X, et al. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol. 2011;61:269-77. 

  22. PLoS One J Ahn 6 e22788 2011 10.1371/journal.pone.0022788 Ahn J, Yang L, Paster BJ, et al. Oral microbiome profiles: 16S rRNA pyrosequencing and microarray assay comparison. PLoS One. 2011;6:e22788. 

  23. Proc Natl Acad Sci ML Sogin 103 12115 2006 10.1073/pnas.0605127103 Sogin ML, Morrison HG, Huber JA, et al. Microbial diversity in the deep sea and the underexplored “rare biosphere”. Proc Natl Acad Sci. 2006;103:12115-20. 

  24. BMC Biol T Stoeck 7 72 2009 10.1186/1741-7007-7-72 Stoeck T, Behnke A, Christen R, et al. Massively parallel tag sequencing reveals the complexity of anaerobic marine protistan communities. BMC Biol. 2009;7:72. 

  25. Genome Res M Hamady 19 1141 2009 10.1101/gr.085464.108 •• Hamady M, Knight R. Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res. 2009;19:1141-52. The paper addresses the challenges in high-throughput sequencing and also addresses one key question emerging from various Human Microbiome Projects: Is there a substantial core of abundant organisms or lineages that we all share? 

  26. 10.1093/bib/bbq077 Ledergerber C, Dessimoz C. Base-calling for next-generation sequencing platforms. Brief Bioinform. 2011. doi: 10.1093/bib/bbq077 . 

  27. World J Gastroenterol CW Nossa 16 4135 2010 10.3748/wjg.v16.i33.4135 Nossa CW, Oberdorf WE, Yang L, et al. Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol. 2010;16:4135-44. 

  28. Appl Environ Microbiol KE Wommack 74 1453 2008 10.1128/AEM.02181-07 Wommack KE, Bhavsar J, Ravel J. Metagenomics: read length matters. Appl Environ Microbiol. 2008;74:1453-63. 

  29. Nat Meth JG Caporaso 7 335 2010 10.1038/nmeth.f.303 Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Meth. 2010;7:335-6. 

  30. Appl Environ Microbiol TZ DeSantis 72 5069 2006 10.1128/AEM.03006-05 DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069-72. 

  31. Genome Res DH Huson 17 377 2007 10.1101/gr.5969107 Huson DH, Auch AF, Qi J, et al. MEGAN analysis of metagenomic data. Genome Res. 2007;17:377-86. 

  32. Genome Res BJ Haas 21 494 2011 10.1101/gr.112730.110 Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21:494-504. 

  33. Int J Syst Bacteriol RA Clayton 45 595 1995 10.1099/00207713-45-3-595 Clayton RA, Sutton G, Hinkle PS, et al. Intraspecific variation in small-subunit rRNA sequences in GenBank: why single sequences may not adequately represent prokaryotic taxa. Int J Syst Bacteriol. 1995;45:595-9. 

  34. J Clin Microbiol JM Janda 45 2761 2007 10.1128/JCM.01228-07 Janda JM, Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 2007;45:2761-4. 

  35. Appl Environ Microbiol KE Ashelford 71 7724 2005 10.1128/AEM.71.12.7724-7736.2005 Ashelford KE, Chuzhanova NA, Fry JC, et al. At least 1 in 20 16S rRNA sequence records currently held in public repositories is estimated to contain substantial anomalies. Appl Environ Microbiol. 2005;71:7724-36. 

  36. Nucleic Acids Res JR Cole 37 D141 2009 10.1093/nar/gkn879 Cole JR, Wang Q, Cardenas E, et al. The ribosomal database project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009;37:D141-5. 

  37. 10.1093/database/baq013 Chen T, Yu W-H, Izard J, et al. The human oral microbiome database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database. 2010:baq013. doi: 10.1093/database/baq013 

  38. J Bacteriol FE Dewhirst 192 5002 2010 10.1128/JB.00542-10 • Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192:5002-17. The human oral cavity contains a number of different habitats, including the teeth, gingival sulcus, tongue, cheeks, hard and soft palates, and tonsils, which are colonized by bacteria. The oral microbiome is comprised of over 600 prevalent taxa at the species level, with distinct subsets predominating at different habitats. The HOMD is the first curated description of a human-associated microbiome and provides tools for use in understanding the role of the microbiome in health and disease. 

  39. PLoS One AL Griffen 6 e19051 2011 10.1371/journal.pone.0019051 Griffen AL, Beall CJ, Firestone ND, et al. CORE: a phylogenetically-curated 16S rDNA database of the core oral microbiome. PLoS One. 2011;6:e19051. 

  40. Lancet D Greenspan 357 1411 2001 10.1016/S0140-6736(00)04578-5 Greenspan D, Canchola AJ, MacPhail LA, et al. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet. 2001;357:1411-2. 

  41. J Dent Res D Greenspan 83 145 2004 10.1177/154405910408300212 Greenspan D, Gange SJ, Phelan JA, et al. Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res. 2004;83:145-50. 

  42. Oral Med Oral Pathol Oral Radiol JS Greenspan 73 142 1992 10.1016/0030-4220(92)90185-S Greenspan JS, Barr CE, Sciubba JJ, et al. Oral manifestations of HIV infection: definitions, diagnostic criteria and principles of therapy. Oral Med Oral Pathol Oral Radiol. 1992;73:142-4. 

  43. BMC Oral Health O Hamza 6 12 2006 10.1186/1472-6831-6-12 Hamza O, Matee M, Simon E, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health. 2006;6:12. 

  44. AIDS Patient Care STDs A Ceballos-Salobreña 14 627 2000 10.1089/10872910050206540 Ceballos-Salobreña A, Gaitán-Cepeda LA, Ceballos-Garcia L, et al. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? AIDS Patient Care STDs. 2000;14:627-35. 

  45. Community Dent Oral Epidemiol R Mulligan 36 549 2008 10.1111/j.1600-0528.2008.00443.x Mulligan R, Seirawan H, Alves ME, et al. Oral health-related quality of life among HIV-infected and at-risk women. Community Dent Oral Epidemiol. 2008;36:549-57. 

  46. Oral Surg Oral Med Oral Pathol Oral Radiol Endod M Navazesh 100 701 2005 10.1016/j.tripleo.2004.10.011 Navazesh M, Mulligan R, Pogoda J, et al. The effect of HAART on salivary microbiota in the Women’s Interagency HIV study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:701-8. 

  47. J Dent Res JA Phelan 83 869 2004 10.1177/154405910408301109 Phelan JA, Mulligan R, Nelson E, et al. Dental caries in HIV-seropositive women. J Dent Res. 2004;83:869-73. 

  48. J Oral Pathol Med CH Shiboski 38 481 2009 10.1111/j.1600-0714.2009.00749.x Shiboski CH, Patton LL, Webster-Cyriaque JY, et al. The oral HIV/AIDS research alliance: updated case definitions of oral disease endpoints. J Oral Pathol Med. 2009;38:481-8. 

  49. Adv Dent Res CH Shiboski 23 28 2011 10.1177/0022034511399084 •• Shiboski CH, Webster-Cyriaque JY, Ghannoum M, et al. Overview of the oral HIV/AIDS research alliance program. Adv Dent Res. 2011;23:28-33. The Oral HIV/AIDS Research Alliance is part of the AIDS Clinical Trials Group, the largest HIV clinical trial organization in the world, and it is funded by the National Institute of Dental and Craniofacial Research, in collaboration with the National Institute of Allergy and Infectious Diseases. The alliance’s main objective is to investigate the oral complications associated with HIV/AIDS as the epidemic is evolving-in particular, the effects of potent antiretrovirals on the development of oral mucosal lesions and associated fungal and viral pathogens. 

  50. PLoS Med B Auvert 2 e298 2005 10.1371/journal.pmed.0020298 Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2:e298. 

  51. Lancet RC Bailey 369 643 2007 10.1016/S0140-6736(07)60312-2 Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643-56. 

  52. Lancet RH Gray 369 657 2007 10.1016/S0140-6736(07)60313-4 Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657-66. 

  53. PLoS One LB Price 5 e8422 2010 10.1371/journal.pone.0008422 •• Price LB, Liu CM, Johnson KE, et al. The effects of circumcision on the penis microbiome. PLoS ONE. 2010;5:e8422. The reduction in putative anaerobic bacteria after circumcision may play a role in protection from HIV and other sexually transmitted diseases. 

  54. N Engl J Med AAR Tobian 360 1298 2009 10.1056/NEJMoa0802556 •• Tobian AAR, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360:1298-309. Male circumcision for the prevention of herpes simplex virus type 2 and human papillomavirus infections and syphilis in HIV-negative adolescent boys and men. 

  55. Lancet MJ Wawer 377 209 2011 10.1016/S0140-6736(10)61967-8 Wawer MJ, Tobian AAR, Kigozi G. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet. 2011;377:209-18. 

  56. Am J Reprod Immunol D Anderson 65 220 2011 10.1111/j.1600-0897.2010.00941.x Anderson D, Politch JA, Pudney J. HIV infection and immune defense of the penis. Am J Reprod Immunol. 2011;65:220-9. 

  57. BJOG RF Lamont 118 533 2011 10.1111/j.1471-0528.2010.02840.x Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011;118:533-49. 

  58. 10.1016/j.tem.2011.06.001 •• White BA, Creedon DJ, Nelson KE. The vaginal microbiome in health and disease. Trends Endocrinol Metabol. 2011;389-93. Authors discussed how next-generation sequencing-based approaches to study the vaginal microbiome will be important for defining what constitutes an imbalance of the microbiome and the associated host conditions that lead to subsequent infection and disease states. 

  59. AIDS Res Hum Retrovir GT Spear 26 193 2010 10.1089/aid.2009.0166 Spear GT, Gilbert D, Sikaroodi M, et al. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res Hum Retrovir. 2010;26:193-200. 

  60. PLoS One R Hummelen 5 e12078 2010 10.1371/journal.pone.0012078 • Hummelen R, Fernandes AD, Macklaim JM, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One. 2010;5:e12078. Illumina-based 16S sequencing technique was used to determine vaginal microbiota among women living with HIV in sub-Saharan Africa. The bacterial profile constitutes several bacteria associated with a normal microbiota or BV. 

  61. J Assoc Nurses AIDS Care JM McMahon 22 9 2011 10.1016/j.jana.2010.05.001 •• McMahon JM, Morrow KM, Weeks M, et al. Potential impact of vaginal microbicides on HIV risk among women with primary heterosexual partners. J Assoc Nurses AIDS Care. 2011;22:9-16. Universal promotion of microbicides could nonetheless lead to an increase in HIV risk among specific subgroups of women, indicating the importance of promoting continued condom use. 

  62. 10.1073/pnas.1002611107 • Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 108 Suppl 2011, 1:4680-7. The inherent differences within and between women in different ethnic groups strongly argue for a more refined definition of the kinds of bacterial communities normally found in healthy women and the need to appreciate differences between individuals so they can be taken into account in risk assessment and disease diagnosis. 

  63. Appl Environ Microbiol GT Spear 77 378 2010 10.1128/AEM.00973-10 Spear GT, Gilbert D, Landay AL, et al. Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals lactobacillus iners as the predominant lactobacillus species. Appl Environ Microbiol. 2010;77:378-81. 

  64. 10.1086/516227 Jousimies-Somer H. Recently described clinically important anaerobic bacteria: taxonomic aspects and update. Clin Infect Dis. 25 Suppl 1997, 2:S78-87. 

  65. Pediatr Res L Peng 2007 61 37 2007 10.1203/01.pdr.0000250014.92242.f3 Peng L, He Z, Chen W, et al. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007;2007(61):37-41. 

  66. Proc Natl Acad Sci U S A WR Wikoff 106 3698 2009 10.1073/pnas.0812874106 Wikoff WR, Anfora AT, Liu J. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009;106:3698-703. 

  67. Int Rev Immunol R Hummelen 29 485 2010 10.3109/08830185.2010.505310 Hummelen R, Vos AP, van't Land B, et al. Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int Rev Immunol. 2010;29:485-513. 

  68. J Virol S Mehandru 81 599 2007 10.1128/JVI.01739-06 Mehandru S, Poles MA, Tenner-Racz K, et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol. 2007;81:599-612. 

  69. Gut A Haas 60 1506 2011 10.1136/gut.2010.224774 Haas A, Zimmermann K, Graw F, et al. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut. 2011;60:1506-19. 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로